Lessons Learned: Medtronic Advises On New Tech Add-On Payment Process
This article was originally published in The Gray Sheet
Executive Summary
Device firms applying for a new technology "add-on" payment should take steps to include Medicare beneficiaries in their clinical trials, according to Medtronic Sofamor Danek Reimbursement Group Director Robert Peterson
You may also be interested in...
First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold
The device industry's hopes to reduce the Centers for Medicare & Medicaid Services' new technology "add-on" payment threshold are riding on a provision in the House's "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1)
Inpatient Payment Rule Provides No New Tech Add-On Payments For Devices
Medtronic Sofamor Danek's InFuse bone graft/LT-Cage lumbar tapered fusion system does not qualify for a new technology add-on payment under the inpatient prospective payment system (IPPS) fiscal 2003 final rule because the device is FDA-approved only for single-level spinal fusion
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.